Trending...
- Paul Ohana - From Beverly Hills Salon Chair To Beauty Founder Celebrity Hair Expert
- Should Older Wood Windows in Southampton Be Repaired or Replaced?
- Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
FAYETTEVILLE, Ark. - Nyenta -- Lineus Medical, maker of SafeBreak Vascular, has seen breakthrough clinical results at multiple hospital systems across the U.S. that validate the clinical and health-economic value proposition for SafeBreak, the first breakaway device for IV lines.
The cumulative data, cultivated through evidence-based medicine and demonstrated across tens of thousands of patients, is convincing and has clearly demonstrated SafeBreak's value, use, and adoption as a true standard of care. Based on the clinical success seen to date, additional capital has been raised to accelerate commercial efforts in the U.S., Europe, Latin America, and Asia.
To support this growth, the company has promoted Larry Hayes to President and Chief Commercial Officer. In his expanded role, Larry will oversee the company's marketing, sales, manufacturing, and human resources functions, consolidating operational leadership under a single point of accountability as Lineus scales its commercial operations.
More on Nyenta.com
"I'm honored to take on this role at such a pivotal moment for Lineus Medical. We have built tremendous momentum over the past year. Stepping into this role, alongside my commercial responsibilities, gives me a broader hand in how we scale our growth long-term. We're not changing direction, we're accelerating it," said Hayes.
"This new leadership structure, alongside recent investments, reflects the confidence we have in Lineus Medical's trajectory. Larry has been instrumental in establishing Lineus' Clinical Evidence Program through the Breakaway Impact Registry, a key to the company's commercial success. This expanded role positions Larry to help lead our next stage of growth," said Jonathon Fite, Chairman of the Board.
CEO and co-founder, Vance Clement, will continue to lead the company with a renewed passion on next generation vascular access solutions. "I am excited to focus on the long-term future of Lineus Medical and the scientific advancement of our intellectual property and product portfolio," said Vance Clement.
More on Nyenta.com
Additionally, Lineus announces the appointment of Pravin Raj to its Board of Directors. Mr. Raj's services and technology background to help organizations scale will complement the company's near-term commercialization and long-term portfolio development goals.
SafeBreak Vascular is a breakaway device for IV lines that separates when a damaging force is applied to IV lines, removing the damaging forces and protecting the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump, and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44%-91%.1 The device is FDA-cleared for use across all vascular lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical
Lineus Medical is the developer of SafeBreak Vascular, a breakaway technology proven to reduce IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical for more on LinkedIn, Facebook, and Instagram.
Reference:
1. Data on File.
The cumulative data, cultivated through evidence-based medicine and demonstrated across tens of thousands of patients, is convincing and has clearly demonstrated SafeBreak's value, use, and adoption as a true standard of care. Based on the clinical success seen to date, additional capital has been raised to accelerate commercial efforts in the U.S., Europe, Latin America, and Asia.
To support this growth, the company has promoted Larry Hayes to President and Chief Commercial Officer. In his expanded role, Larry will oversee the company's marketing, sales, manufacturing, and human resources functions, consolidating operational leadership under a single point of accountability as Lineus scales its commercial operations.
More on Nyenta.com
- StormXR Announces Whack-A-PC for iPhone, iPad, and Android
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- USA Air Management Helps Homeowners Recognize the Signs Their Air Ducts Cleaning Need Staten Island
- Wordeee Publishes 8 Superpowers of Self-Discovery by Award-Winning Author Marina Nicholas
- Michelle Ian Releases New Horror Suspense Thriller - Shadows Are Falling
"I'm honored to take on this role at such a pivotal moment for Lineus Medical. We have built tremendous momentum over the past year. Stepping into this role, alongside my commercial responsibilities, gives me a broader hand in how we scale our growth long-term. We're not changing direction, we're accelerating it," said Hayes.
"This new leadership structure, alongside recent investments, reflects the confidence we have in Lineus Medical's trajectory. Larry has been instrumental in establishing Lineus' Clinical Evidence Program through the Breakaway Impact Registry, a key to the company's commercial success. This expanded role positions Larry to help lead our next stage of growth," said Jonathon Fite, Chairman of the Board.
CEO and co-founder, Vance Clement, will continue to lead the company with a renewed passion on next generation vascular access solutions. "I am excited to focus on the long-term future of Lineus Medical and the scientific advancement of our intellectual property and product portfolio," said Vance Clement.
More on Nyenta.com
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
Additionally, Lineus announces the appointment of Pravin Raj to its Board of Directors. Mr. Raj's services and technology background to help organizations scale will complement the company's near-term commercialization and long-term portfolio development goals.
SafeBreak Vascular is a breakaway device for IV lines that separates when a damaging force is applied to IV lines, removing the damaging forces and protecting the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump, and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44%-91%.1 The device is FDA-cleared for use across all vascular lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical
Lineus Medical is the developer of SafeBreak Vascular, a breakaway technology proven to reduce IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical for more on LinkedIn, Facebook, and Instagram.
Reference:
1. Data on File.
Source: Lineus Medical
0 Comments
Latest on Nyenta.com
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- RecallMode Helps Students Study Without Clock-Watching or Forced Timer Interruptions
- Mandeville Pests May Pose Serious Health Risks for Your Family
- Nancy Pirri Releases New Contemporary Fake Fiancé Romance Novel - Play Along, Sweetheart
- Do I Need New Windows? Southampton Homeowners May Have Another Option
- Launching Book Club: The Board Perspective in Today's Changing Political Economy
- Wordeee Publishes Beyond Control, Extraordinary Story of John Gano's Life
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- Wordeee Imprint, Riverchild Literary Press, Publishes Alpha Whisperers™
- Excel Class Launches New Training Program: Power BI Data Analytics & Dashboard Development
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- As AI Data Centers Strain Power Grids, Everyday People Get Paid to Power the Web from Home PCs
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Former California Sergeant Exposes America's Broken Prison System
- The ABC's of Insurance Celebrates 600th TV Episode
- PerfectvilleUSA to Officially Launch New App at New York Fashion Week With Perfect Population SS27
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
- Raja Limousine Targets the "Last 20 Miles" of International Travel With NYC Airport Service


